Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients

Name: Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients
Creator: ClinicalTrials.gov
Published: 2026-07-12T01:58:48+08:00

DataMed2026-07-12 收录

小细胞肺癌化疗

临床疗效评估

数据链接：

https://datamed.org/dataset/61bf91b3-e99c-4ad5-808e-34d504d1983b 数据链接链接失效反馈

官方服务：

资源简介：

- Primary : To determine the safety profile of each treatment group. - Secondary : To determine efficacy in term of overall response, disease free survival and survival at 1 and 2 years.

提供机构：

ClinicalTrials.gov

Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients

资源简介：

相关数据集